Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer? 

Professor Eliezer Flescher of The Sackler Faculty of Medicine, thinks so.  He & his colleagues have developed an anti cancer drug based on a decade of research into the commercial applications of the compound Jasmonate, a synthetic compound derived from the flower itself.

According to the professor both blood cancers and solid tumors seem to be responsive to the compound know as methyl jasmonate and he is hopeful that an anti cancer drug based on jasmonate could be on the shelf in America within four years through the activity of Sepal-Pharma which liscensed his research.  Professor Flescher’s published his findings most recently in the academic journal Oncogene.

source: Eureka alert! medicine